BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 27915193)

  • 1. Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC-MS, LC-MS
    Caspar AT; Brandt SD; Stoever AE; Meyer MR; Maurer HH
    J Pharm Biomed Anal; 2017 Feb; 134():158-169. PubMed ID: 27915193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
    Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques.
    Caspar AT; Westphal F; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2018 Jan; 410(3):897-912. PubMed ID: 28762065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
    Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MS
    Michely JA; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2017 Feb; 409(6):1681-1695. PubMed ID: 27933361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, "LC-(High Resolution)-MSn" and "LC-(High Resolution)-MS/MS".
    A Michely JA; Manier SK; Caspar AT; Brandt SD; Wallach J; Maurer HH
    Curr Neuropharmacol; 2017; 15(5):692-712. PubMed ID: 27758707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
    Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
    Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.
    Michely JA; Helfer AG; Brandt SD; Meyer MR; Maurer HH
    Anal Bioanal Chem; 2015 Oct; 407(25):7831-42. PubMed ID: 26297461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a Urine and Hair Validated LC-MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat.
    Nisbet LA; Venson R; Wylie FM; Scott KS
    J Anal Toxicol; 2017 Jul; 41(6):559-565. PubMed ID: 28830123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro characterization of potential CYP- and UGT-derived metabolites of the psychoactive drug 25B-NBOMe using LC-high resolution MS.
    Boumrah Y; Humbert L; Phanithavong M; Khimeche K; Dahmani A; Allorge D
    Drug Test Anal; 2016 Feb; 8(2):248-56. PubMed ID: 26382567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC-MS/MS in case of severe intoxications.
    Wiergowski M; Aszyk J; Kaliszan M; Wilczewska K; Anand JS; Kot-Wasik A; Jankowski Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1041-1042():1-10. PubMed ID: 27992785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low resolution and high resolution MS for studies on the metabolism and toxicological detection of the new psychoactive substance methoxypiperamide (MeOP).
    Meyer MR; Holderbaum A; Kavanagh P; Maurer HH
    J Mass Spectrom; 2015 Oct; 50(10):1163-74. PubMed ID: 26456786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
    Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
    Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.
    Poklis JL; Raso SA; Alford KN; Poklis A; Peace MR
    J Anal Toxicol; 2015 Oct; 39(8):617-23. PubMed ID: 26378135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication.
    Poklis JL; Nanco CR; Troendle MM; Wolf CE; Poklis A
    Drug Test Anal; 2014; 6(7-8):764-9. PubMed ID: 24000244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenidine, a new psychoactive substance: metabolic fate elucidated with rat urine and human liver preparations and detectability in urine using GC-MS, LC-MS
    Wink CS; Michely JA; Jacobsen-Bauer A; Zapp J; Maurer HH
    Drug Test Anal; 2016 Oct; 8(10):1005-1014. PubMed ID: 26811026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano liquid chromatography-high-resolution mass spectrometry for the identification of metabolites of the two new psychoactive substances N-(ortho-methoxybenzyl)-3,4-dimethoxyamphetamine and N-(ortho-methoxybenzyl)-4-methylmethamphetamine.
    Caspar AT; Meyer MR; Westphal F; Weber AA; Maurer HH
    Talanta; 2018 Oct; 188():111-123. PubMed ID: 30029353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Recognition Evaluation and Chemical Confirmation of a 25C-NBOMe-Impaired Driver.
    Rajotte JW; Palmentier JFP; Wallage HR
    J Forensic Sci; 2017 Sep; 62(5):1410-1413. PubMed ID: 28261791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.
    Gatch MB; Dolan SB; Forster MJ
    Behav Pharmacol; 2017 Aug; 28(5):375-385. PubMed ID: 28537942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.